,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,21.1,Alopecia,2,16002538
1,21.1,Psychological trauma,6,16002538
0,21.1,Alopecia,2,16002657
0,21.1,Alopecia,3,16002662
0,21.1,Alopecia,3,16002677
0,21.1,Alopecia,2,16002697
0,21.1,Psychological trauma,6,16002707
1,21.1,Alopecia,2,16002707
0,21.1,Alopecia,2,16002734
1,21.1,Psychological trauma,6,16002734
0,22.0,Psychological trauma,6,16002738
1,22.0,Alopecia,2,16002738
2,22.0,Anxiety,6,16002738
0,22.0,Alopecia,2,16002747
1,22.0,Psychological trauma,6,16002747
0,21.1,Prostate cancer,6,16002789
1,21.1,Disease progression,6,16002789
0,21.1,Psychological trauma,6,16002825
1,21.1,Alopecia,2,16002825
0,22.0,Psychological trauma,6,16002830
1,22.0,Alopecia,2,16002830
0,21.1,Alopecia,2,16002843
1,21.1,Psychological trauma,6,16002843
0,22.0,Psychological trauma,6,16002848
1,22.0,Alopecia,2,16002848
0,21.1,Alopecia,2,16002871
0,22.0,Impaired quality of life,6,16002882
1,22.0,Psychological trauma,6,16002882
2,22.0,Emotional distress,6,16002882
3,22.0,Alopecia,2,16002882
4,22.0,Pain,6,16002882
5,22.0,Anxiety,6,16002882
0,22.0,Alopecia,2,16002955
1,22.0,Psychological trauma,6,16002955
0,22.0,Psychological trauma,6,16002962
1,22.0,Alopecia,2,16002962
0,22.0,Alopecia,3,16002969
0,22.0,Alopecia,2,16002973
1,22.0,Psychological trauma,6,16002973
0,21.1,Psychological trauma,6,16002974
1,21.1,Alopecia,2,16002974
0,22.1,Alopecia,2,16002988
0,22.0,Psychological trauma,6,16003010
1,22.0,Alopecia,2,16003010
0,21.1,Alopecia,2,16003022
1,21.1,Psychological trauma,6,16003022
0,21.1,Myalgia,1,16003229
1,21.1,Joint stiffness,1,16003229
2,21.1,Erythema,6,16003229
3,21.1,Arthralgia,1,16003229
4,21.1,Tenderness,1,16003229
5,21.1,Pain in extremity,1,16003229
6,21.1,Chills,1,16003229
7,21.1,Nausea,6,16003229
0,21.1,Hepatotoxicity,3,16003237
0,22.0,Malignant neoplasm progression,5,16003289
1,22.0,Ascites,2,16003289
2,22.0,Oedema peripheral,6,16003289
3,22.0,Cerebral infarction,5,16003289
0,22.0,Anaemia,6,16003308
1,22.0,Infusion related reaction,1,16003308
2,22.0,Pneumonia,5,16003308
3,22.0,Pyrexia,4,16003308
4,22.0,Vitamin B12 decreased,6,16003308
0,21.1,Pulmonary mass,6,16003390
0,21.1,Metastases to central nervous system,3,16003406
0,21.1,Confusional state,1,16003582
1,21.1,Fall,1,16003582
2,21.1,Inappropriate antidiuretic hormone secretion,2,16003582
0,21.1,Asthenia,3,16003625
1,21.1,Decreased appetite,6,16003625
2,21.1,Still^s disease,3,16003625
3,21.1,Neutrophilia,3,16003625
4,21.1,Hyperthermia,1,16003625
5,21.1,Hyperferritinaemia,2,16003625
6,21.1,C-reactive protein increased,2,16003625
0,22.0,Urinary tract disorder,6,16003782
1,22.0,Anaemia,2,16003782
2,22.0,Anuria,1,16003782
3,22.0,Acute kidney injury,1,16003782
4,22.0,Atrial fibrillation,6,16003782
5,22.0,Nephritis,1,16003782
6,22.0,Renal disorder,6,16003782
0,22.0,Diarrhoea,1,16003791
1,22.0,Discomfort,1,16003791
0,22.0,Malaise,2,16003805
1,22.0,Chills,2,16003805
2,22.0,Headache,1,16003805
3,22.0,Hypotension,2,16003805
4,22.0,Hot flush,1,16003805
0,21.1,Pulmonary fibrosis,3,16003813
0,21.1,Fall,6,16003817
1,21.1,Asthenia,2,16003817
2,21.1,Vertigo,2,16003817
0,21.1,Rash,1,16003820
1,21.1,Skin hyperpigmentation,1,16003820
0,21.1,Condition aggravated,3,16003872
1,21.1,Metastases to bone,3,16003872
2,21.1,Prostatic specific antigen increased,3,16003872
0,21.1,Interstitial lung disease,6,16003881
0,22.0,Immune-mediated adverse reaction,1,16003899
1,22.0,Tumour pseudoprogression,6,16003899
2,22.0,Intestinal obstruction,3,16003899
3,22.0,Immune-mediated adverse reaction,1,16003899
4,22.0,Pneumonitis,1,16003899
5,22.0,Pneumonitis,1,16003899
6,22.0,Small intestinal perforation,6,16003899
0,21.1,Disease progression,6,16003909
0,22.0,Encephalitis,6,16003933
1,22.0,Seizure,6,16003933
0,22.0,Malignant neoplasm progression,5,16003934
1,22.0,Liver disorder,3,16003934
0,21.1,Diabetes mellitus,5,16003966
1,21.1,Immune-mediated adverse reaction,5,16003966
2,21.1,Inappropriate schedule of product administration,6,16003966
0,21.1,Osteonecrosis of jaw,6,16003976
1,21.1,Exposed bone in jaw,3,16003976
2,21.1,Inflammation,3,16003976
0,21.1,Malignant neoplasm progression,6,16004017
1,21.1,Breast cancer,6,16004017
2,21.1,Tremor,3,16004017
3,21.1,Drug ineffective,6,16004017
0,21.1,Osteonecrosis of jaw,1,16004025
0,21.1,Pneumonitis,1,16004030
1,21.1,Off label use,6,16004030
0,21.1,Cardiomyopathy,3,16004036
0,21.1,Keratopathy,3,16004062
1,21.1,Visual impairment,1,16004062
0,21.1,Pulmonary oedema,5,16004077
1,21.1,Acute kidney injury,5,16004077
0,21.1,Asthenia,6,16004080
1,21.1,Diarrhoea,6,16004080
2,21.1,Aphthous ulcer,6,16004080
0,21.1,Leukopenia,2,16004088
1,21.1,Neutropenia,2,16004088
0,21.1,Dysuria,3,16004090
1,21.1,Malaise,3,16004090
2,21.1,Haematuria,3,16004090
3,21.1,Mucosal inflammation,3,16004090
4,21.1,Pyrexia,3,16004090
0,21.1,General physical condition abnormal,1,16004203
0,21.1,Troponin increased,6,16004205
1,21.1,Tri-iodothyronine increased,6,16004205
2,21.1,Thyroxine increased,6,16004205
3,21.1,Tachycardia,6,16004205
4,21.1,Blood thyroid stimulating hormone decreased,6,16004205
5,21.1,Drug interaction,6,16004205
0,21.1,Type 2 diabetes mellitus,3,16004212
0,21.1,Prostate cancer,6,16004225
1,21.1,Retching,6,16004225
2,21.1,Death,5,16004225
3,21.1,Asthenia,6,16004225
0,21.1,Asthenia,1,16004250
1,21.1,Decreased appetite,1,16004250
2,21.1,Nausea,1,16004250
0,21.1,Myocarditis,2,16004277
0,22.0,Rash,6,16004304
1,22.0,Nausea,6,16004304
0,21.1,Diarrhoea,,16004319
0,21.1,Dizziness,1,16004334
1,21.1,Paralysis,1,16004334
2,21.1,Paraesthesia,1,16004334
3,21.1,Dyskinesia,1,16004334
0,21.1,Vulvovaginal inflammation,3,16004339
1,21.1,Vulvovaginal pain,3,16004339
2,21.1,Perineal pain,3,16004339
0,21.1,Pneumonia,,16004345
1,21.1,Cardiac disorder,,16004345
2,21.1,Stent placement,,16004345
3,21.1,Pulmonary oedema,,16004345
0,21.1,Death,,16004362
0,21.1,Death,,16004396
0,21.1,Thrombosis,6,16004420
1,21.1,Erysipelas,1,16004420
0,21.1,Death,,16004444
0,21.1,Pyrexia,1,16004457
1,21.1,Atrial fibrillation,3,16004457
2,21.1,Neutropenia,1,16004457
3,21.1,Pyelonephritis,1,16004457
4,21.1,Urinary tract infection,1,16004457
5,21.1,Tachycardia,1,16004457
6,21.1,Atrial fibrillation,1,16004457
0,21.1,Mucosal inflammation,2,16004466
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,2,16004466
0,21.1,Leukopenia,6,16004475
1,21.1,Thrombocytopenia,6,16004475
2,21.1,Neutropenia,6,16004475
0,21.1,Burning sensation,3,16004511
1,21.1,Pain in extremity,3,16004511
2,21.1,Sensitive skin,3,16004511
0,21.1,Rash,6,16004513
0,22.0,Acute kidney injury,2,16004522
0,21.1,Disease progression,,16004536
1,21.1,Acute myeloid leukaemia,5,16004536
0,21.1,Malignant neoplasm progression,6,16004541
0,21.1,Febrile neutropenia,1,16004563
1,21.1,Peripheral sensory neuropathy,2,16004563
2,21.1,Neutrophil count decreased,1,16004563
3,21.1,Stomatitis,2,16004563
0,21.1,Drug dependence,1,16004569
0,21.1,Product use in unapproved indication,6,16004618
1,21.1,Renal failure,6,16004618
2,21.1,Hepatic failure,6,16004618
3,21.1,Cardiac arrest,6,16004618
4,21.1,Death,5,16004618
5,21.1,Septic shock,6,16004618
6,21.1,Adrenal disorder,6,16004618
0,22.1,Cholangitis sclerosing,2,16004651
0,21.1,Dehydration,,16004670
0,21.1,Tumour lysis syndrome,2,16004671
0,21.1,Death,,16004730
0,21.1,Dermatitis exfoliative generalised,1,16004765
1,21.1,Pruritus,1,16004765
0,21.1,Pneumonia,5,16004766
1,21.1,Respiratory failure,5,16004766
0,22.0,Feeling abnormal,6,16004828
1,22.0,Nausea,6,16004828
2,22.0,Sinusitis,6,16004828
3,22.0,Malaise,6,16004828
4,22.0,Dysphagia,6,16004828
5,22.0,Musculoskeletal chest pain,6,16004828
6,22.0,Hypertension,1,16004828
7,22.0,Fatigue,6,16004828
0,21.1,Osteonecrosis of jaw,1,16004844
0,21.1,Sepsis,5,16004854
1,21.1,Neutropenia,3,16004854
0,21.1,Defaecation urgency,1,16004863
1,21.1,Nausea,1,16004863
2,21.1,Feeling hot,1,16004863
3,21.1,Hyperhidrosis,1,16004863
0,21.1,Febrile neutropenia,1,16004942
0,21.1,Alanine aminotransferase increased,1,16004953
1,21.1,Diarrhoea,3,16004953
2,21.1,Decreased appetite,1,16004953
3,21.1,Malaise,6,16004953
4,21.1,Concomitant disease aggravated,6,16004953
5,21.1,Dehydration,6,16004953
6,21.1,Hepatic function abnormal,2,16004953
7,21.1,Nausea,1,16004953
8,21.1,Dysgeusia,6,16004953
0,21.1,Metastases to central nervous system,5,16004993
1,21.1,Status epilepticus,5,16004993
2,21.1,Malignant neoplasm progression,5,16004993
3,21.1,Feeling abnormal,6,16004993
4,21.1,Seizure,5,16004993
5,21.1,Breast cancer metastatic,5,16004993
0,21.1,Death,5,16005040
0,22.1,Death,5,16005066
0,21.1,Death,5,16005119
0,21.1,Feeling abnormal,6,16005222
1,21.1,Emotional disorder,6,16005222
0,22.0,Diarrhoea,6,16005250
1,22.0,Gastrooesophageal reflux disease,6,16005250
0,22.0,Eructation,2,16005304
1,22.0,Feeding disorder,6,16005304
2,22.0,Vomiting,2,16005304
3,22.0,Diarrhoea,1,16005304
4,22.0,Hyperhidrosis,6,16005304
5,22.0,Gastric disorder,1,16005304
6,22.0,Malaise,2,16005304
0,22.0,Neoplasm progression,6,16005350
1,22.0,Off label use,6,16005350
2,22.0,Product use in unapproved indication,6,16005350
0,22.0,Hair colour changes,3,16005384
1,22.0,Hair disorder,3,16005384
2,22.0,Madarosis,3,16005384
3,22.0,Alopecia,3,16005384
4,22.0,Hair texture abnormal,3,16005384
0,21.1,Hypertension,6,16005405
1,21.1,Biliary fistula,6,16005405
2,21.1,Lumbar vertebral fracture,6,16005405
0,21.1,Malignant neoplasm progression,6,16005455
1,21.1,Headache,3,16005455
0,22.0,Diarrhoea,6,16005457
1,22.0,Pharyngeal haemorrhage,5,16005457
0,21.1,Nausea,5,16005460
1,21.1,Acute kidney injury,5,16005460
2,21.1,Ileus paralytic,,16005460
3,21.1,Hypothermia,5,16005460
4,21.1,Asthenia,5,16005460
5,21.1,Diarrhoea,5,16005460
0,22.0,Pneumonitis,1,16005500
1,22.0,Gastrooesophageal reflux disease,2,16005500
0,22.1,Product dose omission,6,16005521
1,22.1,Urinary tract infection,6,16005521
2,22.1,Seizure,6,16005521
0,21.1,Adverse event,6,16005596
1,21.1,Adverse event,6,16005596
2,21.1,Adverse event,6,16005596
3,21.1,Product use in unapproved indication,6,16005596
0,21.1,Interstitial lung disease,2,16005620
0,21.1,Fatigue,3,16005626
1,21.1,Insomnia,3,16005626
2,21.1,Muscle spasms,3,16005626
3,21.1,Decreased appetite,3,16005626
4,21.1,Nausea,3,16005626
5,21.1,Oral pain,3,16005626
6,21.1,Weight decreased,3,16005626
7,21.1,Ammonia increased,3,16005626
0,21.1,Feeling cold,1,16005636
1,21.1,Product substitution issue,1,16005636
2,21.1,Arthralgia,1,16005636
3,21.1,Alopecia,1,16005636
0,22.0,Ovarian cancer recurrent,3,16005746
1,22.0,Renal impairment,2,16005746
0,22.0,Nausea,2,16005748
1,22.0,White blood cell count decreased,1,16005748
2,22.0,Ileus,2,16005748
3,22.0,Anaemia,1,16005748
0,22.0,Nausea,2,16005757
1,22.0,Back pain,2,16005757
2,22.0,Dry mouth,2,16005757
3,22.0,Decreased appetite,2,16005757
4,22.0,Fatigue,2,16005757
5,22.0,Feeling abnormal,2,16005757
6,22.0,Malignant neoplasm progression,2,16005757
0,22.0,Adverse event,3,16005771
1,22.0,Gastric disorder,3,16005771
2,22.0,Nausea,3,16005771
3,22.0,Clostridium difficile infection,3,16005771
4,22.0,Platelet count decreased,3,16005771
5,22.0,Malignant neoplasm progression,6,16005771
6,22.0,Fatigue,3,16005771
7,22.0,Asthenia,3,16005771
8,22.0,Diarrhoea,3,16005771
0,21.1,Diarrhoea,6,16005790
1,21.1,Generalised oedema,2,16005790
2,21.1,Dermatitis acneiform,6,16005790
3,21.1,Paronychia,6,16005790
4,21.1,Weight increased,3,16005790
5,21.1,Hypomagnesaemia,6,16005790
6,21.1,Deep vein thrombosis,6,16005790
0,21.1,Hepatotoxicity,6,16005822
1,21.1,Metastases to liver,6,16005822
0,22.0,Lung infection,1,16005823
1,22.0,Infective exacerbation of chronic obstructive airways disease,6,16005823
0,21.1,Hepatotoxicity,6,16005867
0,21.1,Malignant neoplasm progression,6,16005872
0,22.0,Neurodermatitis,2,16005874
1,22.0,Immune-mediated adverse reaction,2,16005874
0,22.0,Rash,2,16005875
1,22.0,Decreased appetite,1,16005875
2,22.0,Sepsis,2,16005875
3,22.0,Pyrexia,1,16005875
4,22.0,Weight decreased,1,16005875
5,22.0,Inflammatory marker increased,2,16005875
6,22.0,Night sweats,1,16005875
7,22.0,Dyspnoea exertional,1,16005875
8,22.0,Blood count abnormal,2,16005875
9,22.0,C-reactive protein increased,2,16005875
0,21.1,Hepatotoxicity,6,16005879
0,21.1,Disease progression,,16005922
0,22.1,Hair disorder,3,16005942
1,22.1,Hair colour changes,3,16005942
2,22.1,Madarosis,3,16005942
3,22.1,Alopecia,3,16005942
4,22.1,Hair texture abnormal,3,16005942
0,21.1,Anal incontinence,6,16005984
1,21.1,Herpes zoster,6,16005984
0,21.1,Dermatitis exfoliative generalised,1,16005985
0,21.1,Lacrimation increased,,16005989
0,22.0,Headache,3,16006008
1,22.0,Platelet count decreased,6,16006008
2,22.0,Pulmonary haemorrhage,6,16006008
3,22.0,Haemoptysis,6,16006008
4,22.0,Blood pressure increased,3,16006008
5,22.0,Dyspnoea,6,16006008
6,22.0,Blood urea increased,6,16006008
7,22.0,Blood creatinine increased,6,16006008
0,21.1,Monocyte count decreased,6,16006013
1,21.1,Thrombocytopenia,6,16006013
2,21.1,Anaemia,6,16006013
3,21.1,Neutropenia,6,16006013
0,22.0,Peripheral swelling,3,16006015
1,22.0,Alanine aminotransferase increased,3,16006015
2,22.0,Urinary retention,6,16006015
3,22.0,Oropharyngeal pain,6,16006015
0,21.1,Disease progression,,16006048
0,21.1,Death,5,16006060
0,21.1,Blood pressure increased,,16006124
1,21.1,Rash generalised,,16006124
0,21.1,Influenza like illness,1,16006126
0,22.0,Interstitial lung disease,6,16006142
0,21.1,Urinary tract infection,,16006154
1,21.1,Chromaturia,,16006154
0,21.1,Hospitalisation,,16006164
0,21.1,Drug ineffective,6,16006194
1,21.1,Vomiting,1,16006194
0,21.1,Respiratory failure,2,16006245
1,21.1,Fatigue,2,16006245
2,21.1,Pulmonary arterial pressure abnormal,2,16006245
3,21.1,Cough,2,16006245
4,21.1,Dyspnoea exertional,2,16006245
5,21.1,Interstitial lung disease,2,16006245
0,22.0,Drug ineffective,6,16006249
1,22.0,Metastases to lymph nodes,6,16006249
2,22.0,Metastases to the mediastinum,6,16006249
3,22.0,Nausea,2,16006249
0,21.1,Death,5,16006261
0,22.0,Thrombosis,1,16006269
0,22.0,Serositis,1,16006276
1,22.0,Substance-induced psychotic disorder,1,16006276
2,22.0,Hypopituitarism,1,16006276
0,22.0,Blood calcium increased,6,16006349
1,22.0,Death,5,16006349
2,22.0,Incoherent,6,16006349
0,21.1,Death,5,16006357
0,21.1,Malaise,6,16006362
0,21.1,Knee arthroplasty,2,16006373
0,21.1,Ileus,1,16006384
0,21.1,Madarosis,3,16006388
1,21.1,Hair colour changes,3,16006388
2,21.1,Hair disorder,3,16006388
3,21.1,Hair texture abnormal,3,16006388
4,21.1,Alopecia,3,16006388
0,21.1,Weight decreased,6,16006417
1,21.1,Drug effective for unapproved indication,6,16006417
0,21.1,Acute kidney injury,3,16006462
0,21.1,Alopecia,3,16006466
1,21.1,Hair texture abnormal,3,16006466
2,21.1,Madarosis,3,16006466
3,21.1,Hair disorder,3,16006466
4,21.1,Hair colour changes,3,16006466
0,22.0,Renal cell carcinoma,3,16006488
1,22.0,Malignant neoplasm progression,3,16006488
2,22.0,Hypertension,1,16006488
3,22.0,Malaise,6,16006488
4,22.0,Diarrhoea,1,16006488
5,22.0,Headache,6,16006488
6,22.0,Constipation,1,16006488
0,21.1,Cyst,6,16006519
0,21.1,Bone marrow failure,2,16006567
0,21.1,Constipation,3,16006574
1,21.1,Diarrhoea,3,16006574
2,21.1,Decreased appetite,3,16006574
3,21.1,White blood cell count decreased,3,16006574
4,21.1,Pulmonary oedema,3,16006574
0,21.1,Acute promyelocytic leukaemia,6,16006589
0,22.0,Hypokalaemia,3,16006599
1,22.0,Diarrhoea,1,16006599
0,21.1,Loss of consciousness,6,16006610
0,21.1,Malignant neoplasm progression,5,16006618
0,21.1,Adverse drug reaction,6,16006620
1,21.1,Gastroenteritis,1,16006620
0,21.1,Gastric ulcer haemorrhage,6,16006718
1,21.1,Cerebrovascular accident,6,16006718
0,21.1,Granulocytopenia,2,16006769
0,21.1,Metastases to bone,3,16006840
1,21.1,Metastases to lymph nodes,3,16006840
2,21.1,Prostatic specific antigen increased,3,16006840
3,21.1,Performance status decreased,,16006840
4,21.1,Asthenia,,16006840
0,22.1,Ileus,6,16006857
1,22.1,Intestinal obstruction,3,16006857
2,22.1,Malignant neoplasm progression,6,16006857
0,22.0,Malignant neoplasm progression,6,16006879
0,21.1,Malaise,6,16006899
1,21.1,Fall,6,16006899
2,21.1,Dysphonia,6,16006899
3,21.1,Abdominal discomfort,6,16006899
4,21.1,Nausea,6,16006899
5,21.1,Blood pressure increased,6,16006899
6,21.1,Contusion,6,16006899
7,21.1,Inappropriate schedule of product administration,6,16006899
8,21.1,Asthenia,6,16006899
9,21.1,Decreased appetite,6,16006899
0,21.1,Hepatic enzyme increased,1,16006911
1,21.1,Gastrointestinal disorder,6,16006911
2,21.1,Pancytopenia,2,16006911
3,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,16006911
0,21.1,Malignant neoplasm progression,5,16006957
0,21.1,Colonic abscess,6,16006965
1,21.1,Malignant neoplasm progression,6,16006965
2,21.1,Sepsis,6,16006965
0,22.1,Transfusion,6,16006973
1,22.1,Blood count abnormal,6,16006973
2,22.1,Nausea,6,16006973
3,22.1,Constipation,1,16006973
4,22.1,Gastrointestinal stoma complication,1,16006973
0,21.1,Interstitial lung disease,6,16006976
1,21.1,Metastases to central nervous system,6,16006976
0,21.1,Product dose omission,6,16006983
1,21.1,Adverse event,6,16006983
0,21.1,No adverse event,6,16007018
1,21.1,Product dose omission,6,16007018
0,22.0,Polyneuropathy,6,16007019
1,22.0,Palmoplantar keratoderma,6,16007019
2,22.0,Neutropenia,6,16007019
3,22.0,Neurotoxicity,6,16007019
4,22.0,Diarrhoea,6,16007019
0,21.1,Dysuria,1,16007028
1,21.1,Cystitis noninfective,1,16007028
2,21.1,Neuropathy peripheral,1,16007028
3,21.1,Mucosal inflammation,1,16007028
4,21.1,Diarrhoea,1,16007028
5,21.1,Rash,1,16007028
6,21.1,Urosepsis,1,16007028
7,21.1,Anaphylactic reaction,1,16007028
8,21.1,Dyspnoea,1,16007028
9,21.1,Palmar erythema,3,16007028
10,21.1,Escherichia test positive,3,16007028
11,21.1,Hypersensitivity,1,16007028
12,21.1,Bacterial test positive,1,16007028
13,21.1,Urinary tract infection,1,16007028
14,21.1,Malaise,1,16007028
15,21.1,Defaecation urgency,3,16007028
16,21.1,Chest discomfort,1,16007028
17,21.1,Fatigue,3,16007028
18,21.1,Tendonitis,3,16007028
19,21.1,Tremor,1,16007028
20,21.1,Neuropathy peripheral,1,16007028
21,21.1,Hypertension,1,16007028
22,21.1,Erythema,1,16007028
0,22.0,Fatigue,1,16007030
1,22.0,Vertigo,1,16007030
0,21.1,Bradycardia,6,16007041
1,21.1,Atrioventricular block first degree,6,16007041
2,21.1,Bundle branch block right,6,16007041
0,21.1,Interstitial lung disease,6,16007048
0,22.0,Leukopenia,1,16007098
1,22.0,Hyperkalaemia,3,16007098
2,22.0,Presyncope,1,16007098
3,22.0,Syncope,1,16007098
4,22.0,Malaise,1,16007098
5,22.0,Sciatica,1,16007098
0,21.1,Aortic aneurysm,6,16007142
1,21.1,Product use in unapproved indication,6,16007142
0,22.0,Gastrointestinal perforation,1,16007162
1,22.0,Intestinal obstruction,1,16007162
2,22.0,Incarcerated inguinal hernia,1,16007162
3,22.0,Infectious pleural effusion,1,16007162
0,21.1,Drug ineffective,6,16007171
1,21.1,Condition aggravated,3,16007171
2,21.1,Metastases to bone,3,16007171
0,21.1,Diarrhoea haemorrhagic,1,16007172
0,21.1,Shock symptom,6,16007175
1,21.1,Hypersensitivity,6,16007175
0,21.1,Skin ulcer,6,16007180
1,21.1,Eschar,6,16007180
2,21.1,Fracture,6,16007180
3,21.1,Fungal skin infection,6,16007180
4,21.1,Dermatitis exfoliative generalised,6,16007180
0,22.1,Nausea,1,16007181
1,22.1,Interstitial lung disease,6,16007181
2,22.1,Malignant neoplasm progression,6,16007181
3,22.1,Lymphangiosis carcinomatosa,6,16007181
4,22.1,Decreased appetite,1,16007181
0,21.1,Blood bilirubin increased,3,16007199
1,21.1,Metastases to liver,3,16007199
2,21.1,Bile duct obstruction,3,16007199
0,21.1,Oligohydramnios,3,16007255
1,21.1,Maternal exposure during pregnancy,6,16007255
0,21.1,Nausea,1,16007257
1,21.1,Generalised erythema,1,16007257
2,21.1,Pruritus generalised,1,16007257
3,21.1,Abdominal discomfort,1,16007257
0,22.0,Scleroderma,2,16007258
0,21.1,Nephropathy toxic,6,16007269
0,22.1,Hepatocellular injury,1,16007279
0,22.0,Adverse event,6,16007280
1,22.0,Adverse event,6,16007280
0,21.1,Gastrointestinal haemorrhage,6,16007299
1,21.1,Abdominal pain upper,6,16007299
0,21.1,Death,5,16007307
0,22.1,Cardiac failure congestive,1,16007319
1,22.1,Cardiac failure congestive,2,16007319
2,22.1,Pneumonia,1,16007319
0,21.1,Interstitial lung disease,3,16007325
1,21.1,Non-small cell lung cancer recurrent,3,16007325
0,21.1,Myelodysplastic syndrome,2,16007353
0,21.1,Inflammation,3,16007364
1,21.1,Exposed bone in jaw,3,16007364
2,21.1,Osteonecrosis of jaw,6,16007364
0,22.0,Weight decreased,6,16007411
1,22.0,Decreased appetite,6,16007411
2,22.0,Malaise,6,16007411
3,22.0,Neoplasm progression,6,16007411
4,22.0,Dehydration,6,16007411
5,22.0,Fatigue,6,16007411
6,22.0,Retching,6,16007411
0,22.0,Cardiac arrest,5,16007431
1,22.0,Myasthenia gravis,2,16007431
0,22.0,Atrial fibrillation,1,16007475
0,21.1,Sinus tachycardia,6,16007479
0,22.1,Cardiac arrest,5,16007510
1,22.1,Acute kidney injury,5,16007510
2,22.1,Lactic acidosis,5,16007510
3,22.1,Hyperkalaemia,5,16007510
0,22.0,Adverse event,6,16007663
1,22.0,Product use in unapproved indication,6,16007663
0,21.1,Haematochezia,6,16007665
1,21.1,Constipation,6,16007665
2,21.1,Diarrhoea,6,16007665
0,21.1,Asthenia,3,16007666
1,21.1,Still^s disease,3,16007666
2,21.1,Hyperthermia,1,16007666
3,21.1,Off label use,3,16007666
4,21.1,Hyperferritinaemia,2,16007666
5,21.1,Neutrophilia,3,16007666
6,21.1,Decreased appetite,6,16007666
7,21.1,C-reactive protein increased,2,16007666
0,22.1,Bladder disorder,6,16007669
1,22.1,Fatigue,6,16007669
2,22.1,Nasopharyngitis,2,16007669
3,22.1,Sleep disorder,6,16007669
0,21.1,Leukaemia,6,16007697
0,21.1,Pain,3,16007798
1,21.1,Weight decreased,3,16007798
2,21.1,Tongue haemorrhage,1,16007798
3,21.1,Toxicity to various agents,3,16007798
4,21.1,Infection,1,16007798
5,21.1,Fatigue,3,16007798
6,21.1,Malaise,6,16007798
7,21.1,Blood pressure increased,3,16007798
8,21.1,Tongue biting,1,16007798
9,21.1,Diarrhoea,3,16007798
10,21.1,Malignant neoplasm progression,3,16007798
0,21.1,Gait disturbance,3,16007828
1,21.1,Malaise,6,16007828
2,21.1,Vomiting,1,16007828
3,21.1,Metastases to lung,3,16007828
4,21.1,Loss of consciousness,6,16007828
5,21.1,Diarrhoea,1,16007828
6,21.1,Nausea,1,16007828
7,21.1,Metastasis,3,16007828
8,21.1,Mass,6,16007828
9,21.1,General physical health deterioration,3,16007828
0,22.0,Generalised erythema,2,16007841
1,22.0,Hypertransaminasaemia,2,16007841
0,21.1,Rectal haemorrhage,1,16007844
1,21.1,Hepatic cirrhosis,6,16007844
2,21.1,Colitis,6,16007844
3,21.1,Gastritis,6,16007844
0,21.1,Fatigue,6,16007846
1,21.1,Cough,6,16007846
2,21.1,Burn oesophageal,6,16007846
3,21.1,Hepatocellular injury,6,16007846
4,21.1,Skin toxicity,6,16007846
5,21.1,Dysphonia,6,16007846
6,21.1,Aphthous ulcer,6,16007846
0,22.1,Hyperbilirubinaemia,1,16007850
1,22.1,Vertigo,6,16007850
2,22.1,Gastrointestinal toxicity,1,16007850
3,22.1,Gastrointestinal toxicity,6,16007850
4,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,16007850
5,22.1,Musculoskeletal stiffness,6,16007850
6,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,16007850
7,22.1,Jaundice,6,16007850
8,22.1,Nausea,6,16007850
9,22.1,Hepatic function abnormal,6,16007850
10,22.1,General physical health deterioration,6,16007850
11,22.1,Arthralgia,6,16007850
12,22.1,Jaundice,1,16007850
13,22.1,Drug intolerance,1,16007850
14,22.1,Arthralgia,1,16007850
0,21.1,Neutropenia,1,16007859
1,21.1,Nasopharyngitis,1,16007859
2,21.1,Febrile neutropenia,1,16007859
0,21.1,Death,5,16007912
0,21.1,Death,5,16007947
1,21.1,Off label use,6,16007947
2,21.1,Intentional product use issue,6,16007947
0,22.0,Pneumonia,5,16008004
1,22.0,Pneumonitis,3,16008004
0,22.0,Alopecia,6,16008011
1,22.0,Hair disorder,3,16008011
2,22.0,Hair texture abnormal,3,16008011
3,22.0,Hair colour changes,3,16008011
0,21.1,Hair disorder,3,16008020
1,21.1,Hair colour changes,3,16008020
2,21.1,Hair texture abnormal,3,16008020
3,21.1,Madarosis,3,16008020
4,21.1,Alopecia,3,16008020
0,21.1,Alopecia,3,16008032
1,21.1,Hair disorder,3,16008032
2,21.1,Madarosis,3,16008032
3,21.1,Hair texture abnormal,3,16008032
4,21.1,Hair colour changes,3,16008032
0,21.1,Full blood count decreased,6,16008074
0,22.0,Second primary malignancy,1,16008099
1,22.0,Squamous cell carcinoma of the hypopharynx,1,16008099
0,22.0,Gastroenteritis viral,1,16008120
1,22.0,Back pain,2,16008120
2,22.0,Influenza like illness,1,16008120
3,22.0,Musculoskeletal chest pain,2,16008120
0,22.0,Malignant neoplasm progression,6,16008150
0,22.0,Anaemia,1,16008155
1,22.0,Thrombocytopenia,1,16008155
2,22.0,Agranulocytosis,1,16008155
3,22.0,Colony stimulating factor therapy,6,16008155
4,22.0,Febrile neutropenia,1,16008155
0,21.1,Malignant neoplasm progression,5,16008162
1,21.1,Adverse event,6,16008162
2,21.1,Product use in unapproved indication,6,16008162
0,22.0,Neutropenia,3,16008184
1,22.0,Venous thrombosis,3,16008184
0,21.1,Chest pain,3,16008186
1,21.1,Pericarditis,3,16008186
2,21.1,Pleural effusion,3,16008186
0,21.1,Polyserositis,3,16008192
1,21.1,Pleural effusion,3,16008192
2,21.1,Neoplasm progression,3,16008192
0,21.1,Pancytopenia,6,16008248
1,21.1,Dyspnoea exertional,6,16008248
2,21.1,Hypercalcaemia,6,16008248
0,22.0,Breast pain,3,16008290
1,22.0,Pleural effusion,3,16008290
2,22.0,Cough,3,16008290
3,22.0,Ureteric obstruction,1,16008290
4,22.0,Pneumonia,5,16008290
5,22.0,Musculoskeletal chest pain,3,16008290
6,22.0,Breast pain,1,16008290
7,22.0,Pseudomonas infection,3,16008290
0,21.1,Pancytopenia,3,16008305
1,21.1,Pyrexia,3,16008305
0,22.0,Metastases to lung,6,16008315
1,22.0,Haemoglobin decreased,2,16008315
2,22.0,Metastases to liver,6,16008315
3,22.0,Metastases to bone,6,16008315
4,22.0,White blood cell count decreased,6,16008315
5,22.0,Malaise,3,16008315
0,22.0,Sinus tachycardia,6,16008339
1,22.0,Liver disorder,1,16008339
2,22.0,Lymphangiosis carcinomatosa,6,16008339
3,22.0,Interstitial lung disease,2,16008339
4,22.0,Chest X-ray abnormal,6,16008339
0,21.1,Vaginal haemorrhage,1,16008401
1,21.1,Fatigue,3,16008401
2,21.1,Peritonitis,5,16008401
3,21.1,Ascites,1,16008401
4,21.1,Ascites,2,16008401
5,21.1,Muscle spasms,1,16008401
6,21.1,Pain in extremity,1,16008401
0,21.1,Cholecystitis,2,16008416
1,21.1,Hyperplasia,6,16008416
2,21.1,Urticaria,6,16008416
3,21.1,Insomnia,6,16008416
4,21.1,Cholangitis,2,16008416
0,21.1,Tendon disorder,3,16008424
0,21.1,Nausea,3,16008455
1,21.1,Fatigue,3,16008455
2,21.1,Dizziness,3,16008455
3,21.1,Asthenia,3,16008455
4,21.1,Constipation,3,16008455
5,21.1,Oesophageal varices haemorrhage,3,16008455
0,22.0,Pneumonitis,5,16008460
1,22.0,Pneumonia,5,16008460
0,22.1,Anorectal discomfort,6,16008464
1,22.1,Lymphadenopathy,6,16008464
2,22.1,Eye pain,3,16008464
3,22.1,Product dose omission,6,16008464
4,22.1,Visual impairment,6,16008464
5,22.1,Aortic aneurysm,6,16008464
6,22.1,Rectal discharge,6,16008464
7,22.1,Haemorrhage,6,16008464
8,22.1,Blood pressure increased,6,16008464
9,22.1,Fatigue,3,16008464
10,22.1,Asthenia,6,16008464
11,22.1,Osteoarthritis,6,16008464
12,22.1,Cough,3,16008464
13,22.1,Intentional product misuse,6,16008464
0,21.1,Hepatotoxicity,1,16008465
1,21.1,Blood alkaline phosphatase increased,1,16008465
2,21.1,Alanine aminotransferase increased,1,16008465
0,22.0,Death,5,16008474
0,21.1,Toxicity to various agents,1,16008478
1,21.1,Fatigue,6,16008478
0,21.1,Lung disorder,3,16008481
1,21.1,Red blood cell count decreased,3,16008481
2,21.1,Pain in jaw,6,16008481
3,21.1,Back disorder,3,16008481
4,21.1,White blood cell count decreased,3,16008481
5,21.1,Tooth extraction,6,16008481
0,22.0,Testicular abscess,1,16008486
1,22.0,Renal disorder,6,16008486
2,22.0,Inability to afford medication,3,16008486
3,22.0,Underdose,6,16008486
4,22.0,Product dose omission,3,16008486
0,21.1,Chronic obstructive pulmonary disease,3,16008488
1,21.1,Inappropriate schedule of product administration,6,16008488
2,21.1,Migraine,6,16008488
3,21.1,Fatigue,6,16008488
4,21.1,Prostatic specific antigen increased,6,16008488
5,21.1,Somnolence,6,16008488
6,21.1,Headache,6,16008488
7,21.1,Insomnia,6,16008488
8,21.1,Laziness,6,16008488
9,21.1,Hot flush,6,16008488
0,21.1,Off label use,6,16008566
1,21.1,Vaginal discharge,3,16008566
0,21.1,Blindness,6,16008567
0,22.0,Blood glucose increased,1,16008596
1,22.0,Lipids increased,6,16008596
2,22.0,Decreased appetite,1,16008596
3,22.0,Nausea,1,16008596
4,22.0,Neuropathy peripheral,6,16008596
5,22.0,Fatigue,1,16008596
6,22.0,Weight decreased,6,16008596
7,22.0,Haemoglobin decreased,1,16008596
8,22.0,Neutrophil count decreased,1,16008596
9,22.0,Blood pressure increased,1,16008596
10,22.0,Disease progression,6,16008596
11,22.0,Vomiting,1,16008596
12,22.0,White blood cell count decreased,2,16008596
13,22.0,Constipation,2,16008596
14,22.0,Platelet count decreased,1,16008596
0,22.0,Acquired haemophilia,6,16008627
0,21.1,Neutropenia,1,16008645
0,21.1,Death,5,16008662
0,21.1,Blood electrolytes abnormal,1,16008679
0,21.1,Neutropenia,1,16008686
0,22.1,Hypokalaemia,1,16008689
1,22.1,Cellulitis,1,16008689
2,22.1,Ejection fraction decreased,1,16008689
3,22.1,Fatigue,3,16008689
4,22.1,Alopecia,3,16008689
5,22.1,Pain in extremity,3,16008689
0,21.1,Pneumonia,2,16008768
1,21.1,Drug ineffective,3,16008768
0,21.1,Product use in unapproved indication,3,16008786
1,21.1,Mental impairment,3,16008786
2,21.1,Vomiting,1,16008786
3,21.1,Gallbladder disorder,2,16008786
4,21.1,Failure to thrive,3,16008786
0,22.1,Anaemia,2,16008818
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,2,16008818
2,22.1,Neuropathy peripheral,3,16008818
3,22.1,Pneumothorax,1,16008818
4,22.1,Pruritus,1,16008818
5,22.1,Febrile neutropenia,1,16008818
6,22.1,Neutropenia,2,16008818
7,22.1,Leukopenia,1,16008818
8,22.1,Pyrexia,1,16008818
0,21.1,Small intestinal obstruction,6,16008870
0,21.1,Breast cancer metastatic,6,16008882
1,21.1,Osteonecrosis of jaw,2,16008882
0,21.1,Duodenal perforation,5,16008892
1,21.1,Tuberculosis,5,16008892
2,21.1,Diarrhoea,5,16008892
0,22.1,Pulmonary fibrosis,6,16008918
0,22.0,Liver disorder,2,16008929
0,21.1,Corneal lesion,6,16008945
1,21.1,Stevens-Johnson syndrome,1,16008945
0,21.1,Hypertension,6,16009016
1,21.1,Abdominal abscess,6,16009016
2,21.1,Biliary fistula,6,16009016
0,21.1,Mechanical ventilation,3,16009019
1,21.1,Respiratory failure,5,16009019
2,21.1,Pneumonitis,5,16009019
0,22.0,Prostate cancer metastatic,5,16009040
0,21.1,Pancreatitis,6,16009044
0,22.0,Confusional state,1,16009046
0,21.1,Death,5,16009081
0,22.0,Diabetes mellitus,6,16009109
1,22.0,Thyroiditis,6,16009109
2,22.0,Arthritis,6,16009109
0,21.1,Off label use,6,16009196
1,21.1,Tremor,3,16009196
0,21.1,Sepsis,1,16009294
0,22.0,Wrong technique in product usage process,6,16009325
1,22.0,Accidental exposure to product,6,16009325
2,22.0,Device adhesion issue,6,16009325
0,21.1,Diarrhoea,1,16009374
1,21.1,Cataract,1,16009374
0,21.1,Hair disorder,1,16009375
0,21.1,Red blood cell count decreased,6,16009430
1,21.1,Rhinorrhoea,6,16009430
2,21.1,White blood cell count decreased,6,16009430
3,21.1,Platelet count decreased,6,16009430
4,21.1,Epistaxis,6,16009430
5,21.1,Nasal discomfort,6,16009430
0,21.1,Gastric ulcer,3,16009444
0,21.1,Bone pain,6,16009453
1,21.1,Off label use,6,16009453
0,22.0,Product use in unapproved indication,6,16009476
1,22.0,Death,5,16009476
0,22.0,Sequestrectomy,6,16009504
1,22.0,Bone lesion,3,16009504
2,22.0,Neuralgia,3,16009504
3,22.0,Osteonecrosis of jaw,3,16009504
0,22.1,Malignant neoplasm progression,6,16009509
1,22.1,Interstitial lung disease,5,16009509
2,22.1,Disseminated intravascular coagulation,5,16009509
0,22.0,Lung disorder,5,16009593
1,22.0,Pulmonary mass,6,16009593
2,22.0,Mobility decreased,6,16009593
3,22.0,Multiple organ dysfunction syndrome,6,16009593
4,22.0,Metabolic acidosis,6,16009593
5,22.0,Hyponatraemia,6,16009593
6,22.0,Respiratory alkalosis,6,16009593
7,22.0,Malignant neoplasm progression,6,16009593
8,22.0,Malaise,6,16009593
9,22.0,Tumour lysis syndrome,6,16009593
0,22.0,Neutropenia,1,16009596
1,22.0,Chest discomfort,6,16009596
2,22.0,Arthralgia,6,16009596
3,22.0,Headache,1,16009596
4,22.0,Weight increased,3,16009596
5,22.0,Chills,6,16009596
6,22.0,Dyspnoea,6,16009596
7,22.0,Product dose omission,6,16009596
8,22.0,Anxiety,6,16009596
9,22.0,Dizziness,1,16009596
10,22.0,Dehydration,1,16009596
11,22.0,Myalgia,6,16009596
12,22.0,Stress,6,16009596
13,22.0,Red blood cell count decreased,1,16009596
14,22.0,Oedema peripheral,6,16009596
15,22.0,Fatigue,1,16009596
0,21.1,Neurodermatitis,2,16009597
0,21.1,Mucosal dryness,3,16009604
1,21.1,Arthralgia,3,16009604
2,21.1,Insomnia,3,16009604
3,21.1,Nausea,3,16009604
4,21.1,Headache,3,16009604
5,21.1,Trigger finger,1,16009604
6,21.1,Hyperhidrosis,3,16009604
7,21.1,Weight decreased,3,16009604
8,21.1,Urinary tract infection,3,16009604
9,21.1,Irritability,3,16009604
10,21.1,Pruritus,3,16009604
11,21.1,Hot flush,3,16009604
12,21.1,Anxiety,3,16009604
13,21.1,Gamma-glutamyltransferase increased,3,16009604
14,21.1,Asthenia,3,16009604
0,21.1,Full blood count decreased,6,16009623
0,22.0,Alopecia,2,16009724
0,22.0,Pericarditis constrictive,3,16009776
0,21.1,Nausea,6,16009781
1,21.1,Fatigue,6,16009781
2,21.1,Neutropenia,6,16009781
3,21.1,Anaemia,6,16009781
4,21.1,Diarrhoea,6,16009781
5,21.1,Leukopenia,6,16009781
6,21.1,Vomiting,6,16009781
7,21.1,Interstitial lung disease,6,16009781
8,21.1,Abdominal abscess,6,16009781
9,21.1,Embolism,6,16009781
10,21.1,Hypertension,6,16009781
11,21.1,Decreased appetite,6,16009781
0,21.1,Musculoskeletal pain,2,16009831
1,21.1,Bone pain,2,16009831
2,21.1,Oedema peripheral,2,16009831
3,21.1,Decreased appetite,2,16009831
4,21.1,Dizziness,2,16009831
5,21.1,Headache,2,16009831
6,21.1,Fall,2,16009831
7,21.1,Hypoaesthesia,2,16009831
0,21.1,Abdominal pain,3,16009847
0,21.1,Neuropathy peripheral,6,16009865
1,21.1,Malaise,6,16009865
2,21.1,Injection site pain,6,16009865
3,21.1,Dyspnoea,6,16009865
0,21.1,Prostatic specific antigen increased,3,16009869
1,21.1,Malignant neoplasm progression,3,16009869
2,21.1,Urinary retention,3,16009869
3,21.1,Blood testosterone increased,3,16009869
4,21.1,Haematuria,3,16009869
5,21.1,Drug ineffective,,16009869
6,21.1,Drug interaction,,16009869
7,21.1,Back pain,3,16009869
8,21.1,Abdominal pain,3,16009869
0,22.1,Pneumonia,6,16009870
1,22.1,Respiratory tract congestion,6,16009870
2,22.1,Depression,3,16009870
3,22.1,Respiratory tract infection,5,16009870
4,22.1,Cancer pain,6,16009870
5,22.1,Chronic obstructive pulmonary disease,5,16009870
6,22.1,Metastases to bone,6,16009870
7,22.1,Bone pain,3,16009870
0,21.1,Alopecia,2,16009884
0,22.0,Anxiety,6,16009897
1,22.0,Psychological trauma,6,16009897
2,22.0,Alopecia,2,16009897
3,22.0,Emotional distress,6,16009897
0,21.1,Febrile neutropenia,2,16009903
0,22.1,Breast cancer metastatic,5,16009927
1,22.1,Pleural effusion,3,16009927
2,22.1,Peripheral swelling,3,16009927
3,22.1,Dyspnoea,6,16009927
4,22.1,Blood glucose increased,2,16009927
5,22.1,Polyuria,2,16009927
6,22.1,Lower respiratory tract infection,1,16009927
7,22.1,Malignant neoplasm progression,5,16009927
8,22.1,Mobility decreased,3,16009927
9,22.1,Mucosal inflammation,3,16009927
0,21.1,Sepsis,1,16010014
0,21.1,Neuropathy peripheral,6,16010037
1,21.1,Embolism,6,16010037
2,21.1,Sepsis,6,16010037
3,21.1,Thrombocytosis,6,16010037
4,21.1,Hyperglycaemia,6,16010037
5,21.1,Hypocalcaemia,6,16010037
6,21.1,Acute kidney injury,6,16010037
7,21.1,Hyponatraemia,6,16010037
8,21.1,Hypokalaemia,6,16010037
9,21.1,Blood alkaline phosphatase increased,6,16010037
10,21.1,Vomiting,6,16010037
11,21.1,Anaemia,6,16010037
12,21.1,Diarrhoea,6,16010037
13,21.1,Thrombocytopenia,6,16010037
14,21.1,Hypoalbuminaemia,6,16010037
15,21.1,Nausea,6,16010037
16,21.1,Infection,6,16010037
17,21.1,Fatigue,6,16010037
18,21.1,Constipation,6,16010037
19,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,16010037
20,21.1,Leukopenia,6,16010037
21,21.1,Neutropenia,6,16010037
22,21.1,Hypercalcaemia,6,16010037
0,21.1,Exposed bone in jaw,3,16010040
1,21.1,Osteonecrosis of jaw,3,16010040
2,21.1,Inflammation,3,16010040
0,21.1,Tenderness,6,16010081
1,21.1,Swelling face,6,16010081
2,21.1,Osteonecrosis of jaw,3,16010081
3,21.1,Purulence,6,16010081
0,22.0,Lung disorder,5,16010152
1,22.0,Breast cancer,5,16010152
0,21.1,Diarrhoea,1,16010175
1,21.1,Discomfort,1,16010175
0,21.1,Nausea,3,16010211
1,21.1,Kidney infection,6,16010211
2,21.1,Urinary tract infection,6,16010211
3,21.1,Decreased appetite,6,16010211
4,21.1,Dehydration,6,16010211
5,21.1,Somnolence,6,16010211
6,21.1,Intentional dose omission,6,16010211
7,21.1,Diarrhoea,6,16010211
8,21.1,Device occlusion,6,16010211
9,21.1,Peripheral swelling,2,16010211
10,21.1,Nasopharyngitis,6,16010211
11,21.1,Device related infection,6,16010211
0,22.0,Acute respiratory failure,1,16010267
0,21.1,Asthenia,6,16010270
1,21.1,Neutropenia,6,16010270
2,21.1,Malignant neoplasm progression,6,16010270
3,21.1,Breast cancer,6,16010270
4,21.1,Influenza like illness,6,16010270
5,21.1,Nausea,6,16010270
6,21.1,Vomiting,6,16010270
0,22.0,Death,5,16010290
1,22.0,Fatigue,6,16010290
2,22.0,Bone pain,6,16010290
3,22.0,Lung infection,6,16010290
0,21.1,Hepatocellular injury,2,16010340
0,22.1,Dehydration,5,16010344
1,22.1,Inflammation,5,16010344
2,22.1,Interstitial lung disease,5,16010344
3,22.1,Functional gastrointestinal disorder,5,16010344
4,22.1,Blood potassium increased,6,16010344
5,22.1,Oedema,5,16010344
6,22.1,Acute respiratory failure,5,16010344
7,22.1,Pneumonia,5,16010344
8,22.1,Lung disorder,5,16010344
9,22.1,Pulmonary function test abnormal,5,16010344
0,21.1,Lung disorder,6,16010396
1,21.1,Tumour cavitation,6,16010396
0,21.1,Ischiorectal hernia,2,16010410
0,21.1,Wound,1,16010451
0,21.1,Diarrhoea,5,16010532
1,21.1,Nausea,5,16010532
2,21.1,Hypothermia,5,16010532
3,21.1,Acute kidney injury,5,16010532
4,21.1,Asthenia,5,16010532
0,21.1,Hereditary optic atrophy,3,16010566
0,22.1,Alopecia,6,16010567
1,22.1,Peripheral swelling,6,16010567
0,21.1,Fatigue,1,16010588
0,21.1,No adverse event,6,16010592
0,22.0,Hair disorder,3,16010598
1,22.0,Madarosis,3,16010598
2,22.0,Alopecia,3,16010598
3,22.0,Hair texture abnormal,3,16010598
4,22.0,Hair colour changes,3,16010598
0,21.1,Hair colour changes,3,16010600
1,21.1,Alopecia,3,16010600
2,21.1,Hair disorder,3,16010600
3,21.1,Hair texture abnormal,3,16010600
4,21.1,Madarosis,3,16010600
0,21.1,Hair texture abnormal,3,16010605
1,21.1,Hair disorder,3,16010605
2,21.1,Hair colour changes,3,16010605
3,21.1,Depression,6,16010605
4,21.1,Anxiety,6,16010605
5,21.1,Alopecia,3,16010605
6,21.1,Madarosis,3,16010605
0,22.1,Hair colour changes,3,16010614
1,22.1,Alopecia,3,16010614
2,22.1,Hair disorder,3,16010614
3,22.1,Hair texture abnormal,3,16010614
4,22.1,Madarosis,3,16010614
0,21.1,Pancytopenia,1,16010638
0,22.1,Death,5,16010684
1,22.1,Intentional product use issue,6,16010684
0,21.1,Dizziness,1,16010690
1,21.1,Burning sensation,6,16010690
2,21.1,Oral pain,6,16010690
3,21.1,Decreased appetite,1,16010690
4,21.1,Hypersensitivity,6,16010690
5,21.1,Oral mucosal blistering,6,16010690
6,21.1,Oral mucosal exfoliation,6,16010690
7,21.1,Weight increased,6,16010690
8,21.1,Feeding disorder,6,16010690
9,21.1,Weight decreased,6,16010690
10,21.1,Vomiting,6,16010690
0,21.1,Fatigue,4,16010735
1,21.1,Nausea,4,16010735
0,21.1,Ileus,5,16010739
0,21.1,Lactic acidosis,5,16010743
1,21.1,Hyperkalaemia,1,16010743
2,21.1,Acute kidney injury,5,16010743
3,21.1,Cardiac arrest,5,16010743
0,22.0,Drug hypersensitivity,6,16010872
1,22.0,Gastrointestinal haemorrhage,6,16010872
2,22.0,Haemoglobin decreased,6,16010872
0,21.1,Cough,6,16010875
0,21.1,Breast cancer metastatic,1,16010890
1,21.1,Malignant neoplasm progression,1,16010890
0,21.1,Proteinuria,1,16010893
1,21.1,Diarrhoea,3,16010893
2,21.1,Nausea,1,16010893
3,21.1,Thrombosis,1,16010893
4,21.1,Anaemia,1,16010893
5,21.1,Oedema peripheral,1,16010893
6,21.1,Blood urine present,1,16010893
0,22.0,Femur fracture,6,16010940
1,22.0,Pruritus,6,16010940
2,22.0,Blood pressure increased,6,16010940
3,22.0,Pain,6,16010940
4,22.0,Breast pain,6,16010940
5,22.0,Nausea,1,16010940
6,22.0,Infection,6,16010940
7,22.0,Brain neoplasm,6,16010940
0,21.1,Pruritus,1,16010985
1,21.1,Dermatitis exfoliative generalised,1,16010985
0,21.1,Dehydration,1,16011001
0,21.1,Rectal haemorrhage,1,16011012
1,21.1,Venoocclusive liver disease,1,16011012
2,21.1,Portal hypertension,1,16011012
3,21.1,Haematemesis,1,16011012
4,21.1,Varices oesophageal,1,16011012
0,21.1,Multiple organ dysfunction syndrome,5,16011015
1,21.1,Right ventricular enlargement,6,16011015
2,21.1,Depressed level of consciousness,6,16011015
3,21.1,Ejection fraction decreased,6,16011015
4,21.1,Tricuspid valve incompetence,6,16011015
5,21.1,Second primary malignancy,6,16011015
6,21.1,Pneumonia,6,16011015
7,21.1,Tachycardia,6,16011015
8,21.1,Pericardial effusion,6,16011015
9,21.1,Liver disorder,6,16011015
10,21.1,Acute myeloid leukaemia,6,16011015
11,21.1,Generalised oedema,6,16011015
12,21.1,Cardiotoxicity,6,16011015
13,21.1,Human herpesvirus 6 infection,6,16011015
14,21.1,Chest pain,6,16011015
15,21.1,Pyrexia,6,16011015
16,21.1,Graft versus host disease in gastrointestinal tract,6,16011015
17,21.1,Malignant pleural effusion,6,16011015
0,21.1,Multiple-drug resistance,6,16011018
0,21.1,Photosensitivity reaction,2,16011029
0,21.1,Generalised erythema,1,16011035
1,21.1,Nausea,1,16011035
2,21.1,Feeling hot,1,16011035
3,21.1,Circulatory collapse,1,16011035
4,21.1,Hypotension,1,16011035
5,21.1,Malaise,1,16011035
0,21.1,Neutropenia,6,16011037
0,21.1,Rash macular,1,16011042
1,21.1,Erythema of eyelid,1,16011042
2,21.1,Neutropenia,1,16011042
0,21.1,Cyanosis,1,16011046
1,21.1,Flushing,1,16011046
2,21.1,Dyspnoea,1,16011046
0,21.1,Adrenocorticotropic hormone deficiency,6,16011086
0,21.1,Musculoskeletal pain,1,16011138
1,21.1,Abdominal pain,1,16011138
2,21.1,Malignant neoplasm progression,5,16011138
3,21.1,Deep vein thrombosis,2,16011138
4,21.1,Hydronephrosis,1,16011138
0,21.1,Bone lesion,6,16011142
1,21.1,Rhonchi,6,16011142
2,21.1,Candida infection,6,16011142
3,21.1,Musculoskeletal pain,6,16011142
4,21.1,Malignant neoplasm progression,6,16011142
5,21.1,Non-small cell lung cancer metastatic,6,16011142
6,21.1,Wheezing,6,16011142
0,21.1,Syncope,1,16011176
0,21.1,Adverse event,6,16011186
0,21.1,Death,5,16011188
0,21.1,Disease progression,3,16011199
0,22.0,Pulmonary toxicity,2,16011217
1,22.0,Pulmonary fibrosis,6,16011217
0,21.1,Malaise,6,16011260
0,21.1,Weight increased,6,16011267
1,21.1,Product dose omission,6,16011267
2,21.1,Influenza,1,16011267
0,21.1,Metastatic neoplasm,5,16011342
0,21.1,Adverse event,6,16011352
0,21.1,Osteonecrosis,2,16011418
0,21.1,Paralysis,1,16011438
1,21.1,Paraesthesia,1,16011438
2,21.1,Dyskinesia,1,16011438
3,21.1,Dizziness,1,16011438
0,21.1,Rash maculo-papular,2,16011445
0,21.1,Death,5,16011479
1,21.1,Haematotoxicity,6,16011479
2,21.1,Diarrhoea,6,16011479
3,21.1,Neurotoxicity,6,16011479
0,21.1,Condition aggravated,3,16011523
1,21.1,Fatigue,3,16011523
2,21.1,Ageusia,3,16011523
3,21.1,Anosmia,3,16011523
0,22.0,Tonsillitis,1,16011552
1,22.0,Fatigue,6,16011552
2,22.0,Diarrhoea,3,16011552
3,22.0,Nausea,3,16011552
4,22.0,Vomiting,2,16011552
5,22.0,Nausea,2,16011552
6,22.0,Immunodeficiency,6,16011552
0,22.1,Pneumonia,6,16011586
0,22.0,Product dispensing error,6,16011645
1,22.0,Dyspnoea,6,16011645
2,22.0,Fatigue,6,16011645
0,22.0,Malignant pleural effusion,6,16011653
1,22.0,Nausea,1,16011653
2,22.0,Fatigue,3,16011653
3,22.0,Neutropenia,1,16011653
4,22.0,Rash,3,16011653
5,22.0,Vomiting,1,16011653
6,22.0,Chest discomfort,3,16011653
0,21.1,Infection,6,16011695
0,21.1,Haematuria,6,16011747
1,21.1,Urinary tract infection,2,16011747
2,21.1,Bladder pain,6,16011747
3,21.1,Cystitis,6,16011747
0,21.1,Disease progression,6,16011755
0,21.1,Rash,6,16011777
1,21.1,Metastasis,6,16011777
2,21.1,Dyspnoea,6,16011777
3,21.1,Cough,6,16011777
4,21.1,Fatigue,6,16011777
5,21.1,Product blister packaging issue,6,16011777
6,21.1,Pulmonary oedema,6,16011777
0,22.0,Respiratory failure,5,16011804
1,22.0,Intentional product use issue,5,16011804
2,22.0,Pneumocystis jirovecii pneumonia,5,16011804
3,22.0,Off label use,5,16011804
4,22.0,Cytomegalovirus infection,6,16011804
0,21.1,Transaminases increased,,16011873
0,21.1,Hypophagia,6,16011906
1,21.1,Weight decreased,1,16011906
2,21.1,Dysgeusia,1,16011906
3,21.1,Dehydration,3,16011906
4,21.1,Malaise,6,16011906
5,21.1,Epistaxis,6,16011906
6,21.1,Diarrhoea,1,16011906
7,21.1,Rash,6,16011906
8,21.1,Cough,3,16011906
9,21.1,Dry mouth,6,16011906
10,21.1,Fatigue,2,16011906
11,21.1,Abdominal discomfort,1,16011906
0,22.1,White blood cell count decreased,1,16011927
0,21.1,Diarrhoea,,16011943
0,21.1,Rhinitis,,16011954
1,21.1,Oral pain,,16011954
2,21.1,Osteoporosis,,16011954
0,21.1,Inappropriate antidiuretic hormone secretion,2,16011970
1,21.1,Fall,1,16011970
2,21.1,Confusional state,1,16011970
0,21.1,Hypertension,,16011997
0,22.0,Polyneuropathy,1,16012010
1,22.0,Malignant neoplasm progression,6,16012010
2,22.0,Weight decreased,6,16012010
3,22.0,Discomfort,6,16012010
4,22.0,Febrile neutropenia,1,16012010
5,22.0,Metastatic gastric cancer,6,16012010
6,22.0,Stomatitis,1,16012010
0,21.1,Neuropathy peripheral,,16012012
1,21.1,Disease progression,,16012012
2,21.1,Drug ineffective,,16012012
0,21.1,Dizziness,3,16012013
0,21.1,Uterine leiomyoma,6,16012014
0,22.0,Decreased appetite,1,16012032
1,22.0,Night sweats,1,16012032
2,22.0,C-reactive protein increased,2,16012032
3,22.0,Rash,2,16012032
4,22.0,Dyspnoea exertional,1,16012032
5,22.0,Dyspnoea exertional,1,16012032
6,22.0,Decreased appetite,1,16012032
7,22.0,Pyrexia,1,16012032
8,22.0,Inflammatory marker increased,2,16012032
9,22.0,Night sweats,1,16012032
10,22.0,Sepsis,2,16012032
11,22.0,Weight decreased,1,16012032
12,22.0,Blood count abnormal,2,16012032
13,22.0,Pyrexia,1,16012032
0,22.0,Death,5,16012069
1,22.0,Breast cancer,6,16012069
0,21.1,Neutropenia,6,16012071
1,21.1,Metastases to chest wall,6,16012071
2,21.1,Vertigo,2,16012071
3,21.1,Malignant neoplasm progression,6,16012071
4,21.1,Thrombocytopenia,6,16012071
5,21.1,Nausea,2,16012071
6,21.1,Metastases to neck,6,16012071
7,21.1,Metastases to spine,6,16012071
8,21.1,Breast cancer,6,16012071
0,22.1,Anaemia,1,16012075
1,22.1,Renal impairment,1,16012075
2,22.1,Nausea,2,16012075
3,22.1,Taste disorder,1,16012075
0,21.1,Ileus,6,16012093
1,21.1,Intestinal perforation,3,16012093
0,21.1,Infusion related reaction,1,16012097
1,21.1,Burning sensation,1,16012097
2,21.1,Headache,1,16012097
3,21.1,Chest pain,1,16012097
0,21.1,Neutropenia,2,16012107
1,21.1,Pneumonia bacterial,2,16012107
0,21.1,Pneumonitis,1,16012218
1,21.1,Dyspnoea at rest,1,16012218
0,22.0,Platelet count decreased,3,16012224
1,22.0,Haemolytic anaemia,3,16012224
0,21.1,Gastroenteritis viral,1,16012295
1,21.1,Decreased appetite,1,16012295
2,21.1,Headache,1,16012295
3,21.1,Myalgia,1,16012295
4,21.1,Neuropathy peripheral,1,16012295
5,21.1,Catheter site bruise,1,16012295
6,21.1,Diarrhoea,1,16012295
7,21.1,Arthralgia,1,16012295
8,21.1,Vomiting,1,16012295
9,21.1,Mucosal inflammation,1,16012295
10,21.1,Pyrexia,1,16012295
11,21.1,Nasopharyngitis,1,16012295
12,21.1,Oropharyngeal pain,1,16012295
13,21.1,Neuropathy peripheral,1,16012295
14,21.1,Fatigue,1,16012295
15,21.1,Cough,1,16012295
0,21.1,Tumour lysis syndrome,1,16012320
0,21.1,Colon cancer,5,16012322
1,21.1,Disease progression,5,16012322
0,21.1,Herpes zoster,2,16012329
1,21.1,Underdose,6,16012329
0,21.1,Diarrhoea,1,16012339
1,21.1,Lethargy,3,16012339
2,21.1,Heart rate increased,3,16012339
3,21.1,Hypotension,3,16012339
4,21.1,Frequent bowel movements,,16012339
5,21.1,Melaena,3,16012339
0,21.1,Rash generalised,,16012340
1,21.1,Malaise,,16012340
2,21.1,Chills,,16012340
3,21.1,Fatigue,3,16012340
4,21.1,Transfusion,,16012340
5,21.1,Fatigue,,16012340
6,21.1,Pre-existing condition improved,,16012340
7,21.1,Headache,,16012340
8,21.1,Dysphonia,3,16012340
9,21.1,Off label use,,16012340
0,21.1,White blood cell count decreased,,16012401
0,22.0,Anaemia,2,16012421
1,22.0,Malignant neoplasm of eyelid,2,16012421
2,22.0,Physical deconditioning,2,16012421
3,22.0,Febrile neutropenia,1,16012421
4,22.0,Thrombocytopenia,2,16012421
5,22.0,Bone marrow failure,6,16012421
0,21.1,Myasthenic syndrome,5,16012432
0,21.1,Diarrhoea,6,16012470
1,21.1,Hepatocellular injury,2,16012470
2,21.1,Hyperbilirubinaemia,2,16012470
3,21.1,Bile duct stone,6,16012470
4,21.1,Nausea,6,16012470
5,21.1,Pruritus,6,16012470
0,21.1,Drug intolerance,6,16012496
1,21.1,Vomiting,6,16012496
2,21.1,Thrombocytopenic purpura,6,16012496
3,21.1,Febrile neutropenia,6,16012496
4,21.1,Diarrhoea,6,16012496
5,21.1,Anaemia,6,16012496
6,21.1,Nausea,6,16012496
0,21.1,Acute promyelocytic leukaemia,6,16012506
0,21.1,Acute promyelocytic leukaemia,3,16012509
0,22.0,Tuberculosis,6,16012515
1,22.0,Off label use,6,16012515
2,22.0,Drug interaction,6,16012515
0,22.0,Haematochezia,6,16012572
1,22.0,Decreased appetite,6,16012572
2,22.0,Abdominal pain,6,16012572
3,22.0,Haemoglobin decreased,6,16012572
4,22.0,Platelet count decreased,1,16012572
5,22.0,Ageusia,6,16012572
6,22.0,Diarrhoea,6,16012572
7,22.0,Adverse drug reaction,6,16012572
8,22.0,Faeces discoloured,6,16012572
0,21.1,Malignant neoplasm progression,6,16012637
0,21.1,Metastases to central nervous system,6,16012640
0,21.1,Product dose omission,6,16012653
1,21.1,No adverse event,6,16012653
2,21.1,Product supply issue,6,16012653
0,21.1,Anaphylactic shock,2,16012669
0,21.1,Neutropenia,6,16012670
1,21.1,Ileus,6,16012670
0,21.1,Pulmonary alveolar haemorrhage,2,16012696
1,21.1,Liver disorder,6,16012696
0,21.1,Hepatitis B reactivation,1,16012713
1,21.1,Neutropenia,1,16012713
0,22.0,Drug ineffective,6,16012742
1,22.0,Fatigue,3,16012742
2,22.0,Accidental underdose,6,16012742
3,22.0,Neuropathy peripheral,3,16012742
4,22.0,Dry skin,3,16012742
0,21.1,Colitis,1,16012753
1,21.1,Ascites,1,16012753
2,21.1,Hypertension,6,16012753
0,22.0,Proteinuria,6,16012754
1,22.0,Adrenomegaly,6,16012754
2,22.0,Subdural haematoma,5,16012754
0,21.1,Encephalopathy,1,16012757
1,21.1,Hypertension,1,16012757
2,21.1,Oedema,1,16012757
0,22.1,Tracheal fistula,2,16012759
1,22.1,Erythema multiforme,1,16012759
0,22.1,Blood pressure increased,1,16012785
1,22.1,Aortic dissection,2,16012785
0,21.1,Diarrhoea,6,16012794
1,21.1,Asthenia,6,16012794
2,21.1,Platelet count decreased,2,16012794
3,21.1,Bone marrow failure,6,16012794
0,21.1,Neoplasm progression,5,16012837
0,22.0,Congenital haematological disorder,5,16012841
1,22.0,Lymphoedema,5,16012841
2,22.0,Metastases to skin,6,16012841
3,22.0,Infection,6,16012841
4,22.0,Product use in unapproved indication,6,16012841
5,22.0,Deep vein thrombosis,5,16012841
6,22.0,Post thrombotic syndrome,2,16012841
0,21.1,Ankle fracture,2,16012859
0,21.1,Acute coronary syndrome,1,16012883
0,21.1,Pulmonary tuberculosis,6,16012893
0,21.1,Myocardial infarction,6,16012895
0,21.1,Subileus,3,16012901
1,21.1,Urinary retention,3,16012901
2,21.1,Klebsiella test positive,6,16012901
3,21.1,Neutropenia,1,16012901
4,21.1,Constipation,3,16012901
0,21.1,Surgery,,16012928
0,21.1,Candida infection,,16012933
1,21.1,Fungal infection,,16012933
2,21.1,Therapy cessation,,16012933
0,21.1,Neutrophil count decreased,1,16012948
1,21.1,Anaemia,1,16012948
2,21.1,Hypoxia,1,16012948
3,21.1,Catarrh,1,16012948
4,21.1,Alopecia,1,16012948
5,21.1,Asthenia,2,16012948
6,21.1,Diarrhoea,1,16012948
7,21.1,Dysphagia,1,16012948
8,21.1,Pyrexia,1,16012948
9,21.1,Abdominal pain,1,16012948
10,21.1,Febrile neutropenia,1,16012948
11,21.1,Epistaxis,1,16012948
0,21.1,Varices oesophageal,6,16012950
1,21.1,Portal hypertensive gastropathy,6,16012950
2,21.1,Ascites,6,16012950
3,21.1,Waist circumference increased,6,16012950
4,21.1,Neoplasm progression,3,16012950
5,21.1,Haematemesis,2,16012950
6,21.1,Rectal haemorrhage,6,16012950
7,21.1,Gastrointestinal haemorrhage,1,16012950
0,21.1,Disease progression,,16012953
0,21.1,Glomerulonephritis membranous,6,16012960
1,21.1,Nephrotic syndrome,6,16012960
0,21.1,Hypovolaemic shock,5,16012981
1,21.1,Haematochezia,5,16012981
2,21.1,Haematemesis,5,16012981
3,21.1,Upper gastrointestinal haemorrhage,5,16012981
0,21.1,Disease progression,,16012994
0,22.0,Pulmonary embolism,3,16013014
0,21.1,Death,5,16013015
0,21.1,Decreased appetite,6,16013025
1,21.1,Fatigue,6,16013025
2,21.1,Dizziness,6,16013025
3,21.1,Pneumonia,6,16013025
0,21.1,Malignant neoplasm progression,5,16013026
0,22.0,Death,5,16013090
0,21.1,Blood bilirubin increased,3,16013092
1,21.1,Hypermagnesaemia,3,16013092
2,21.1,Alanine aminotransferase increased,3,16013092
3,21.1,Aspartate aminotransferase increased,3,16013092
4,21.1,Blood lactate dehydrogenase increased,3,16013092
5,21.1,Blood alkaline phosphatase increased,3,16013092
0,21.1,Cardiac arrest,6,16013096
0,21.1,Diarrhoea,1,16013112
1,21.1,Insomnia,1,16013112
2,21.1,Arthralgia,6,16013112
3,21.1,Hepatic failure,3,16013112
4,21.1,Peripheral sensory neuropathy,4,16013112
5,21.1,Dysgeusia,6,16013112
6,21.1,Stomatitis,4,16013112
7,21.1,Transaminases abnormal,6,16013112
8,21.1,Rhinitis,3,16013112
9,21.1,Myalgia,6,16013112
0,21.1,Disease progression,,16013149
0,21.1,Death,,16013206
0,21.1,Death,,16013213
0,21.1,Death,,16013355
0,21.1,Acute kidney injury,5,16013406
1,21.1,Hyperkalaemia,1,16013406
2,21.1,Lactic acidosis,5,16013406
3,21.1,Cardiac arrest,5,16013406
0,21.1,Constipation,,16013444
1,21.1,Arthralgia,,16013444
2,21.1,Myalgia,,16013444
3,21.1,Rash,,16013444
4,21.1,Dysphagia,,16013444
0,21.1,Chest pain,6,16013461
0,22.0,Metastases to bone,6,16013472
1,22.0,Cancer pain,6,16013472
2,22.0,Cardiac arrest,5,16013472
3,22.0,Malignant neoplasm progression,5,16013472
4,22.0,Metastases to lymph nodes,6,16013472
5,22.0,Pneumonia bacterial,2,16013472
6,22.0,Nausea,6,16013472
7,22.0,Pleural effusion,6,16013472
8,22.0,Interstitial lung disease,5,16013472
9,22.0,Decreased appetite,2,16013472
10,22.0,Lymphangiosis carcinomatosa,6,16013472
11,22.0,Pericardial effusion,6,16013472
0,21.1,Cushing^s syndrome,6,16013487
0,22.0,Off label use,6,16013488
1,22.0,Muscular weakness,3,16013488
2,22.0,Prescribed underdose,6,16013488
0,21.1,Neuropathy peripheral,3,16013496
0,22.0,Dyspnoea,6,16013502
1,22.0,Eyelid oedema,6,16013502
2,22.0,Protein urine,2,16013502
3,22.0,Weight decreased,2,16013502
4,22.0,Oedema peripheral,6,16013502
5,22.0,Pleural effusion,6,16013502
0,22.0,Ejection fraction decreased,6,16013505
1,22.0,Skin odour abnormal,6,16013505
2,22.0,Rash,3,16013505
3,22.0,Oedema peripheral,6,16013505
4,22.0,Nausea,6,16013505
5,22.0,Pain,6,16013505
6,22.0,Blood pressure fluctuation,2,16013505
7,22.0,Decreased appetite,6,16013505
8,22.0,Rhinitis atrophic,2,16013505
9,22.0,Blood pressure increased,6,16013505
10,22.0,Dry skin,6,16013505
11,22.0,Fatigue,3,16013505
12,22.0,Epistaxis,2,16013505
0,21.1,Exposed bone in jaw,6,16013512
0,22.0,Gingival bleeding,6,16013514
1,22.0,Asthenia,6,16013514
2,22.0,Fatigue,6,16013514
3,22.0,Back pain,6,16013514
0,22.0,Decreased appetite,2,16013532
1,22.0,Fatigue,2,16013532
2,22.0,Oesophageal perforation,3,16013532
3,22.0,Malignant neoplasm progression,5,16013532
4,22.0,Pneumonia,6,16013532
0,21.1,Flushing,,16013568
1,21.1,Injection site pain,,16013568
2,21.1,Nausea,,16013568
0,21.1,Death,5,16013593
0,22.0,Alopecia,2,16013656
0,21.1,Blood test abnormal,2,16013661
1,21.1,Multiple organ dysfunction syndrome,2,16013661
2,21.1,Blood calcium decreased,2,16013661
3,21.1,Blood potassium decreased,2,16013661
4,21.1,Blood magnesium decreased,2,16013661
0,21.1,Death,5,16013663
0,21.1,Psychological trauma,6,16013672
1,21.1,Alopecia,2,16013672
0,21.1,Alopecia,2,16013676
0,21.1,Alopecia,3,16013680
0,22.0,Alopecia,2,16013682
0,22.0,Impaired quality of life,6,16013687
1,22.0,Anxiety,6,16013687
2,22.0,Alopecia,2,16013687
3,22.0,Emotional distress,6,16013687
4,22.0,Pain,6,16013687
5,22.0,Psychological trauma,6,16013687
0,22.0,Alopecia,3,16013719
1,22.0,Pain,6,16013719
2,22.0,Impaired quality of life,6,16013719
3,22.0,Anxiety,6,16013719
4,22.0,Emotional distress,6,16013719
5,22.0,Psychological trauma,6,16013719
0,22.1,Dehydration,3,16013757
1,22.1,Fatigue,3,16013757
2,22.1,Abdominal pain upper,6,16013757
3,22.1,Diarrhoea,3,16013757
4,22.1,Decreased appetite,1,16013757
5,22.1,Back pain,6,16013757
6,22.1,Ulcer,6,16013757
7,22.1,Headache,3,16013757
8,22.1,Nausea,3,16013757
9,22.1,Bone pain,6,16013757
10,22.1,Tremor,6,16013757
11,22.1,Dizziness,3,16013757
12,22.1,Asthenia,6,16013757
13,22.1,Vision blurred,6,16013757
14,22.1,Seasonal allergy,3,16013757
15,22.1,Nephrolithiasis,6,16013757
16,22.1,Anaemia,6,16013757
17,22.1,Blood pressure increased,2,16013757
18,22.1,Anxiety,1,16013757
19,22.1,Nasopharyngitis,3,16013757
20,22.1,Rash,3,16013757
21,22.1,Pruritus,3,16013757
22,22.1,Sneezing,3,16013757
23,22.1,Alopecia,6,16013757
24,22.1,Seborrhoea,3,16013757
25,22.1,Malaise,6,16013757
26,22.1,Proteinuria,6,16013757
27,22.1,Myalgia,6,16013757
28,22.1,Kidney infection,1,16013757
29,22.1,Vomiting,6,16013757
0,21.1,Diarrhoea,6,16013764
1,21.1,Red blood cell count decreased,6,16013764
2,21.1,Constipation,6,16013764
3,21.1,Fatigue,6,16013764
4,21.1,White blood cell count decreased,6,16013764
5,21.1,Abdominal pain,6,16013764
0,22.1,Road traffic accident,6,16013830
1,22.1,Lymphoedema,6,16013830
2,22.1,Tremor,6,16013830
3,22.1,Neoplasm progression,6,16013830
4,22.1,Arthropathy,6,16013830
5,22.1,Laboratory test abnormal,1,16013830
6,22.1,Fatigue,6,16013830
7,22.1,Haemoglobin decreased,6,16013830
8,22.1,Asthenia,6,16013830
0,21.1,Alopecia,2,16013845
1,21.1,Psychological trauma,6,16013845
0,22.0,Pleural effusion,6,16013866
1,22.0,Ascites,6,16013866
2,22.0,Oedema peripheral,2,16013866
3,22.0,Blood alkaline phosphatase increased,6,16013866
4,22.0,Hyponatraemia,1,16013866
5,22.0,Neoplasm progression,6,16013866
6,22.0,Gamma-glutamyltransferase increased,6,16013866
7,22.0,Back pain,6,16013866
8,22.0,Aspartate aminotransferase increased,6,16013866
9,22.0,Pericardial effusion,6,16013866
10,22.0,Transaminases increased,6,16013866
11,22.0,Platelet count increased,6,16013866
12,22.0,Bronchitis,6,16013866
13,22.0,Gastrointestinal hypomotility,6,16013866
14,22.0,Off label use,6,16013866
15,22.0,Alanine aminotransferase increased,6,16013866
16,22.0,General physical health deterioration,2,16013866
17,22.0,Hypokalaemia,1,16013866
18,22.0,Osteonecrosis of jaw,6,16013866
19,22.0,Decreased appetite,6,16013866
20,22.0,Anaemia,3,16013866
21,22.0,Dyspnoea,6,16013866
22,22.0,Asthenia,2,16013866
23,22.0,Tachycardia,6,16013866
24,22.0,Cardiac failure,6,16013866
25,22.0,Cardiovascular disorder,6,16013866
0,21.1,Perirectal abscess,3,16013871
0,21.1,Dyspnoea,6,16013873
1,21.1,Malignant neoplasm progression,6,16013873
2,21.1,Acute respiratory failure,1,16013873
3,21.1,Hypoxia,6,16013873
0,21.1,Tumour haemorrhage,2,16013875
0,22.0,Malignant neoplasm progression,6,16013892
1,22.0,Vomiting,2,16013892
2,22.0,Paraneoplastic neurological syndrome,3,16013892
3,22.0,Subileus,6,16013892
0,21.1,Metastases to bone,6,16013897
1,21.1,Drug resistance,6,16013897
2,21.1,Malignant neoplasm progression,6,16013897
3,21.1,Metastases to liver,6,16013897
4,21.1,Alopecia,6,16013897
5,21.1,Fatigue,6,16013897
6,21.1,Metastases to spine,6,16013897
0,22.0,Lung infection,1,16013994
1,22.0,Cardiac failure,6,16013994
2,22.0,Torsade de pointes,6,16013994
3,22.0,Ventricular tachycardia,6,16013994
4,22.0,Cardio-respiratory arrest,6,16013994
5,22.0,Hypokalaemia,1,16013994
6,22.0,Ventricular fibrillation,1,16013994
7,22.0,Amnesia,6,16013994
8,22.0,Respiratory failure,6,16013994
0,21.1,Renal failure,6,16014011
0,22.0,Splenomegaly,3,16014028
1,22.0,Varices oesophageal,2,16014028
2,22.0,Focal nodular hyperplasia,3,16014028
3,22.0,Thrombocytopenia,6,16014028
4,22.0,Portal hypertension,3,16014028
5,22.0,Alanine aminotransferase increased,6,16014028
0,22.0,Prinzmetal angina,6,16014029
1,22.0,Chest pain,6,16014029
2,22.0,Electrocardiogram ST segment depression,6,16014029
3,22.0,Electrocardiogram ST segment elevation,6,16014029
0,21.1,Staphylococcus test positive,1,16014073
1,21.1,Thrombocytopenia,1,16014073
2,21.1,Dyspnoea,1,16014073
0,22.0,Neoplasm progression,5,16014089
1,22.0,Oesophagitis,6,16014089
2,22.0,Dysphonia,6,16014089
3,22.0,Pneumonia,6,16014089
4,22.0,Gastritis,6,16014089
5,22.0,Abdominal pain upper,2,16014089
6,22.0,Abdominal distension,6,16014089
7,22.0,Lung disorder,6,16014089
8,22.0,Hyperbilirubinaemia,6,16014089
9,22.0,Nausea,3,16014089
10,22.0,Blood pressure fluctuation,6,16014089
11,22.0,Headache,1,16014089
12,22.0,Hepatic failure,6,16014089
13,22.0,Peritonitis bacterial,6,16014089
14,22.0,Jaundice,6,16014089
15,22.0,Malaise,6,16014089
16,22.0,Dyspnoea,6,16014089
0,21.1,Pneumonia,6,16014090
1,21.1,Full blood count decreased,1,16014090
2,21.1,Diverticulum,6,16014090
3,21.1,Respiratory failure,5,16014090
4,21.1,Neoplasm progression,5,16014090
5,21.1,Cardiac failure congestive,6,16014090
6,21.1,Granulomatous liver disease,6,16014090
7,21.1,Pulmonary oedema,6,16014090
8,21.1,Hepatic cyst,6,16014090
0,22.1,Atrial fibrillation,6,16014091
1,22.1,Mitral valve prolapse,6,16014091
2,22.1,Hypersensitivity,6,16014091
3,22.1,Alopecia,3,16014091
4,22.1,Pain,6,16014091
5,22.1,Heart rate increased,6,16014091
6,22.1,Platelet count decreased,3,16014091
7,22.1,Blood pressure decreased,2,16014091
8,22.1,White blood cell count decreased,6,16014091
9,22.1,Blood count abnormal,6,16014091
10,22.1,Diarrhoea,6,16014091
0,21.1,Somnolence,6,16014107
1,21.1,Buccal mucosal roughening,3,16014107
2,21.1,Vomiting,6,16014107
3,21.1,Constipation,3,16014107
4,21.1,Colon cancer,5,16014107
0,21.1,Cardiac failure congestive,2,16014121
0,21.1,Death,5,16014131
0,21.1,Liver disorder,6,16014134
1,21.1,Renal disorder,6,16014134
2,21.1,Pain,6,16014134
3,21.1,Death,5,16014134
4,21.1,Ascites,6,16014134
5,21.1,Neoplasm progression,6,16014134
0,21.1,Granuloma annulare,3,16014204
0,22.0,Malignant neoplasm progression,6,16014214
1,22.0,Decreased appetite,6,16014214
2,22.0,Hyponatraemia,6,16014214
0,21.1,Bile duct stenosis,1,16014230
1,21.1,Malignant neoplasm progression,6,16014230
0,21.1,Colon cancer,5,16014231
